AstraZeneca's Nexium Patent Remains Valid
The European Patent Office has reportedly ruled that a patent covering AstraZeneca Plc's blockbuster heartburn drug Nexium is still valid in its amended form despite challenges from four generic competitors....To view the full article, register now.
Already a subscriber? Click here to view full article